1. Kloppel G. Pathology of nonendocrine pancreatic tumors, inThe Pancreas: Biology, Pathobiology, and Disease, 2nd ed., Go VL, Dima E, Gardner J, Lebenthal E, Reber H, Scheele G, eds. Raven, New York 1993; pp. 871–897.
2. Pour P, Althoff J, Kruger FW, Mohr U. A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)-amine.J Natl Cancer Inst 1977; 58: 1449–1453.
3. Pour PM, Wilson R. Experimental pancreas tumor, inCancer of the Pancreas, Moosa AR, ed., William and Wilkins, Baltimore 1980; pp. 37–158.
4. Pour PM, Egami H, Chaney WG, Takiyama Y, Tempero M, Schlom J, Colcher D. Comparative studies on antigen expression in human and experimental pancreatic cancer, inRecent Results in Tumor Diagnosis and Therapy, Klapdor R, ed. W. Zuckschwerdt Verlag München, San Francisco, 1990; pp. 293–296.
5. Smit VTHBM, Boot AJM, Smits AMM, Fleuren GJ, Cornelisse CJ, Bos JL. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas.Nucleic Acids Res 1988; 16: 7773–7782.